EU planning to spend $2.3 billion on advance purchase of vaccines in testing, on behalf of the 27 EU states
European Commission President Ursula von der Leyen is making an attempt to persuade international leaders to sign up for forces and purchase vaccines up the front together, to save you vaccine prices rising because of opposition
Britain is discussing with the European Union whether or not it will be part of a plan by the bloc to steady elements of ability vaccines towards COVID-19, officials in London and Brussels said on Friday.
The UK-EU talks, first reported by the Financial Times, constitute a check of the cooperation required to tackle international emergencies after Brexit.
The EU is making plans to spend around 2 billion euros ($2.3 billion) on the advance purchase of vaccines in testing, on behalf of the 27 EU states.
European Commission President Ursula von der Leyen has said she is making an attempt to persuade “an enormous number” of global leaders to join forces and buy vaccines up the front together, as competition for a vaccine could in any other case boost the fee for everyone.
“We have reached out to the UK, inviting them to express their hobby if they want to take part inside the joint EU technique set up with the aid of the vaccine strategy,” a Commission spokesperson said.
“Discussions are actually ongoing with the UK.”
Asked about the FT document, a British government spokesman confirmed that it was underneath consideration however did not say a decision have been taken.
“Work is ongoing to decide whether and how the United Kingdom participates in the EU Vaccines Strategy,” he stated in a statement.
London is assessing whether the blessings of the European bloc’s bargaining strength to strike deals with global drug corporations outweigh the wider political preference to sever ties with Brussels, the FT file said, citing UK officials.